Recruiting cannabinoid clinical trials
Clinical trials that list cannabidiol, THC, cannabis or another cannabinoid as a studied intervention and that are recruiting now or will start recruiting soon. The list comes from the public ClinicalTrials.gov registry. Being listed here does not mean a treatment works or is safe for you.
Data retrieved: . 188 trials: 133 recruiting, 55 not yet recruiting. Always check the official registry page for the current status.
CannaQ is not affiliated with any trial listed here and does not recruit participants. Contact details and full eligibility criteria are on each official registry page.
Educational content only, not medical advice. CannaQ is independent: it sells nothing and has no sponsors, affiliate links or industry funding. Do not start, stop or change any treatment on your own; talk to a qualified healthcare professional first. Legal status varies by country.
Showing 188 of 188 trials.
-
Recruiting
Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant
- Condition
- Maternal Complications; Pregnancy Complication; Birth Outcomes, Adverse; Pregnancy
- Substance studied
- Cannabidiol (CBD)
- Phase
- Observational study
- Age group
- No age limits stated (children, adults, older adults)
- Countries
- Germany, Italy, United States
- Locations
- Morgantown, United States; Berlin, Germany; Bologna, Italy
- Registry number
- NCT06113237 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Phase II, Randomized, Double-Blind, Multidose Crossover Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnea
- Condition
- Obstructive Sleep Apnea (OSA)
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Chula Vista, United States; Brandon, United States; Jacksonville, United States; Orlando, United States; West Palm Beach, United States; Marrero, United States
Show all 12 locations
Chula Vista, United States; Brandon, United States; Jacksonville, United States; Orlando, United States; West Palm Beach, United States; Marrero, United States; Rockville, United States; Cincinnati, United States; Anderson, United States; Memphis, United States; Dallas, United States; San Antonio, United States - Registry number
- NCT07635563 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Crossover Trial of Cannabidiol (CBD) Versus Placebo for Psychiatric Presentations in Adults With Autism Spectrum Disorder
- Condition
- Autism Spectrum Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT05015439 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Nabilone for Agitation Blinded Intervention Trial
- Condition
- Alzheimer Disease; Agitation
- Substance studied
- Nabilone (synthetic THC analogue)
- Phase
- Phase 3
- Age group
- 55 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Calgary, Canada; Hamilton, Canada; London, Canada; Ottawa, Canada; Toronto, Canada; Whitby, Canada
- Registry number
- NCT04516057 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Targeted Treatment of Obstructive Sleep Apnea With Dronabinol: Proof of Concept and Phase II Clinical Trial
- Condition
- Obstructive Sleep Apnea
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 1 and 2
- Age group
- up to 65 years (children, adults, older adults)
- Countries
- United States
- Locations
- Chicago, United States
- Registry number
- NCT06477952 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
- Condition
- Alcohol Use Disorder (AUD); Withdrawal From Addictive Substance; Detoxification; Craving
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2 and 3
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07148843 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures
- Condition
- Focal Seizures
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 12 years to 75 years (children, adults, older adults)
- Countries
- United States
- Locations
- Phoenix, United States; La Jolla, United States; New Haven, United States; Miami, United States; Tampa, United States; Atlanta, United States
Show all 23 locations
Phoenix, United States; La Jolla, United States; New Haven, United States; Miami, United States; Tampa, United States; Atlanta, United States; Savannah, United States; Chicago, United States; Bethesda, United States; Detroit, United States; Grand Rapids, United States; Edison, United States; New Brunswick, United States; Hawthorne, United States; Raleigh, United States; Cincinnati, United States; Portland, United States; Philadelphia, United States; Memphis, United States; Austin, United States; El Paso, United States; Murray, United States; Seattle, United States - Registry number
- NCT07233239 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Exploring the Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy: A Prospective Study
- Condition
- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients; Metastatic Colorectal Cancer (CRC); Peripheral Neuropathy Due to Chemotherapy
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Philadelphia, United States
- Registry number
- NCT07167446 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Acute Effects of Cannabis on Cognition and Affect
- Condition
- Cannabis Use
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Pullman, United States
- Registry number
- NCT07296874 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Clinical Trial of Titrating Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder: Core Study With Safety Extension Phase
- Condition
- Cannabis Withdrawal
- Substance studied
- Nabilone (synthetic THC analogue)
- Phase
- Phase 3
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Little Rock, United States; Rogers, United States; New Haven, United States; DeLand, United States; Hollywood, United States; Largo, United States
Show all 22 locations
Little Rock, United States; Rogers, United States; New Haven, United States; DeLand, United States; Hollywood, United States; Largo, United States; Tampa, United States; West Palm Beach, United States; Decatur, United States; Norcross, United States; Savannah, United States; Lexington, United States; Baltimore, United States; Las Vegas, United States; Marlton, United States; New York, United States; Staten Island, United States; North Canton, United States; North Charleston, United States; Knoxville, United States; Austin, United States; Houston, United States - Registry number
- NCT07644052 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder
- Condition
- Generalized Anxiety Disorder (GAD); Anxiety Disorders
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years to 45 years (adults)
- Countries
- United States
- Locations
- Detroit, United States
- Registry number
- NCT07123467 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol Pharmacotherapy for Co-occurring Opioid Use Disorder and Chronic Pain
- Condition
- Chronic Pain; Opioid Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT07886606 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Randomized Phase II Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Advanced Pancreatic and Colorectal Cancer (CanPan-C)
- Condition
- Pancreatic Cancer Non-resectable; Pancreatic Cancer Metastatic; Colorectal Cancer Metastatic
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Saint Louis Park, United States
- Registry number
- NCT06605430 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Acute Effects of THC in Older Adult
- Condition
- Age-related Cognitive Decline
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT06948136 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Augmentation With Cannabidiol in First Episode Psychosis: a Double-blind, Randomised Controlled Trial
- Condition
- Psychosis; First Episode Psychosis; Psychotic Disorders; Psychotic Episode
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 16 years to 40 years (children, adults)
- Countries
- Austria, Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Locations
- Vienna, Austria; Augsburg, Germany; Berlin, Germany; Cologne, Germany; Munich, Germany; Athens, Greece
Show all 17 locations
Vienna, Austria; Augsburg, Germany; Berlin, Germany; Cologne, Germany; Munich, Germany; Athens, Greece; Hod HaSharon, Israel; Petah Tikva, Israel; Ramat Gan, Israel; Naples, Italy; Amsterdam, Netherlands; Madrid, Spain; Seville, Spain; Zurich, Switzerland; Cambridge, United Kingdom; London, United Kingdom; Oxford, United Kingdom - Registry number
- NCT06778564 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
- Condition
- Cannabidiol Effects; Driving Performance
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 30 years (adults)
- Countries
- United States
- Locations
- Morgantown, United States
- Registry number
- NCT06686914 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
- Condition
- Alcohol Drinking; Cannabis Use; Cannabis; Alcohol Use Disorder
- Substance studied
- THC (tetrahydrocannabinol); Cannabidiol (CBD); Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 21 years to 50 years (adults)
- Countries
- United States
- Locations
- Providence, United States
- Registry number
- NCT05389930 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Contribution of the Endocannabinoid System to Sex Differences in THC-associated Reward
- Condition
- Cannabis Use Disorder
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 21 years to 45 years (adults)
- Countries
- United States
- Locations
- Charleston, United States
- Registry number
- NCT07815691 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Epidiolex Pilot Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
- Condition
- Sturge, Weber Syndrome (SWS)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 1 month to 18 months (children)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07778810 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)
- Condition
- Opioid Use Disorder (OUD)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- New York, United States; Portland, United States
- Registry number
- NCT06940674 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Pregnenolone as a Treatment for Cannabis Intoxication
- Condition
- Cannabis Intoxication
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07216690 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase 1a "Window Trial" of Cannabidiol (CBD) For Breast Cancer Primary Tumors
- Condition
- Breast Cancer
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Charleston, United States
- Registry number
- NCT06148038 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
- Condition
- Cannabis Intoxication
- Substance studied
- Cannabis (plant material or extract); THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07214155 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Safety and Efficacy of Cannabidiol (CBD) for Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults Using Liquid StructureTM Formulation (NantheiaTM ATL5).
- Condition
- PTSD
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Omaha, United States
- Registry number
- NCT05269459 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine
- Condition
- Alcohol Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT07279558 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Efficacy and Safety of Cannabidiol for Pain Relief of Patients With End-stage Metastatic Castration Resistant Prostate Cancer, a Randomised Double-blinded Placebo-controlled Phase II Trial
- Condition
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- No age limits stated (children, adults, older adults)
- Countries
- Denmark
- Locations
- Gistrup, Denmark
- Registry number
- NCT07549256 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury
- Condition
- Supra-sacral Spinal Cord Injury; Spinal Cord Injury; Urinary Incontinence
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Madison, United States
- Registry number
- NCT06840899 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Randomized, Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Effects of Cannabidiol on Neurobehavioral and Function Outcomes in Sanfilippo Syndrome
- Condition
- Sanfilippo Syndrome; Mucopolysaccharidosis III
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2 and 3
- Age group
- 4 years and older (children, adults, older adults)
- Countries
- United States
- Locations
- Torrance, United States
- Registry number
- NCT06333041 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Differential Effects of THC vs. CBD on Cognition in Persons With MS
- Condition
- Multiple Sclerosis
- Substance studied
- Cannabinol (CBN); Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 26 years to 59 years (adults)
- Countries
- Canada
- Locations
- Calgary, Canada
- Registry number
- NCT06261489 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Pathophysiological Mechanisms of Cannabidiol in Stress Regulation
- Condition
- Early Life Adversity; Trauma; Stress
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 18 years to 25 years (adults)
- Countries
- United States
- Locations
- New York, United States
- Registry number
- NCT07278505 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial
- Condition
- Recurrent Pericarditis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years and older (adults, older adults)
- Countries
- Canada, Greece, Italy, United States
- Locations
- Phoenix, United States; Irvine, United States; La Jolla, United States; Los Angeles, United States; Santa Monica, United States; Jacksonville, United States
Show all 25 locations
Phoenix, United States; Irvine, United States; La Jolla, United States; Los Angeles, United States; Santa Monica, United States; Jacksonville, United States; Chicago, United States; Baltimore, United States; Columbia, United States; Boston, United States; Minneapolis, United States; Rochester, United States; New York, United States; Cleveland, United States; Houston, United States; Salt Lake City, United States; Burlington, United States; Charlottesville, United States; Richmond, United States; Montreal, Canada; Athens, Greece; Milan, Italy; Padua, Italy; Torino, Italy; Udine, Italy - Registry number
- NCT06708299 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Evaluation of Oral THC and CBD in Oral Fluid, Pharmacokinetics, and Subjective and Neurocognitive Effects in Men and Women
- Condition
- Drug Abuse; Intoxication by Drug; Impairment
- Substance studied
- THC (tetrahydrocannabinol); Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Los Angeles, United States
- Registry number
- NCT05067387 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Impact of Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
- Condition
- Cannabis Intoxication; Alcohol Intoxication
- Substance studied
- THC (tetrahydrocannabinol); Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06293040 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
- Condition
- Osteoarthritis, Knee; Osteoarthritis of the Knee
- Substance studied
- Cannabidiol (CBD); Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 21 years to 75 years (adults, older adults)
- Countries
- United States
- Locations
- Ann Arbor, United States
- Registry number
- NCT04992624 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
High Potency Cannabis: Acute and Protracted Effects
- Condition
- Abuse Cannabis; Pain; Pharmacokinetics
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Los Angeles, United States
- Registry number
- NCT06859723 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Pharmacokinetics of a Hemp-Based Topical Cannabinoid Product in a Sanitized and Controlled Environment
- Condition
- Cannabis
- Substance studied
- Cannabidiol (CBD); THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07603518 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
- Condition
- Schizophrenia; Cannabis Use Disorder
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 60 years (adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT06058702 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effects of Topical Cannabidiol on Paramedian Forehead Flap Scar Healing: A Split Scar Study (TOPSCAR)
- Condition
- Paramedian Forehead Flap
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Oklahoma City, United States
- Registry number
- NCT06129591 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome
- Condition
- Fragile X Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 7 years to 40 years (children, adults)
- Countries
- Canada
- Locations
- Sherbrooke, Canada
- Registry number
- NCT06261502 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Use of Cannabidiol Suppositories for Sexual Pain: A Randomised Controlled Study
- Condition
- Well-Being, Psychological; Quality of Life; Sexual Behavior; Sexual Pain Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Not applicable
- Age group
- 18 years to 100 years (adults, older adults)
- Countries
- United Kingdom
- Locations
- London, United Kingdom
- Registry number
- NCT07271030 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effects of Repeated CBD Administration on Cannabis Abuse Liability and Analgesia: A Human Laboratory Study
- Condition
- Cannabis; Abuse Liability; Experimental Pain in Healthy Human Participants
- Substance studied
- Cannabidiol (CBD); Cannabis (plant material or extract)
- Phase
- Early phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT07434895 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
- Condition
- Phobia, Social
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 4
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Cambridge, United States
- Registry number
- NCT05649059 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Developing Predictive Models to Distinguish Alcohol Use, Cannabis Use and Co-use: An Exploration of Electroencephalography (EEG) Metrics and Traditional Intoxication Measures
- Condition
- Cannabis Use; Alcohol Use, Unspecified
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 21 years to 50 years (adults)
- Countries
- United States
- Locations
- Fort Collins, United States
- Registry number
- NCT06259916 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Pharmacological Effects of Cannabidiol on Responses to Stress and Nicotine Withdrawal
- Condition
- CBD; Stress; Nicotine Dependence; Tobacco Smoking
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 21 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07001930 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Wayne Warrior CAnnabis Research and Education: Cannabis and Behavioral Health
- Condition
- Post Traumatic Stress Disorder; Cannabis Use; Suicide; Veterans; Marijuana
- Substance studied
- Cannabinol (CBN); Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 19 years to 69 years (adults, older adults)
- Countries
- United States
- Locations
- Detroit, United States
- Registry number
- NCT06381180 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Randomized, Placebo-Controlled Clinical Trial of Once Daily Oral Cannabis for Weight Loss in Obese Individuals
- Condition
- Obesity
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT06137365 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol Medication Intervention Trial (CALM-IT)
- Condition
- Alzheimer Disease
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 55 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Calgary, Canada; London, Canada; Toronto, Canada; Whitby, Canada
- Registry number
- NCT06014424 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
PAIN-GP: Project Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
- Condition
- Endometriosis; Adenomyosis; Chronic Pelvic Inflammatory Disease
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Belmont, United States
- Registry number
- NCT07728695 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
MC-RWE : Real World Evidence in Patient-Reported Outcomes for Medical Cannabis: A Prospective Observational Study
- Condition
- Pain; Sleep; Anxiety; Depression; Epilepsy
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Observational study
- Age group
- 19 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT04526093 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Naturally Produced Cannabinoids for Pain Management and Neuroprotection From Concussion During Participation in Contact Sports: Neuroprotection
- Condition
- Healthy
- Substance studied
- Cannabinoid (type as described in the registry)
- Phase
- Phase 2
- Age group
- 19 years to 35 years (adults)
- Countries
- Canada
- Locations
- Regina, Canada
- Registry number
- NCT07715864 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Mechanisms of Cannabidiol (CBD) in Persons With Multiple Sclerosis (MS): the Role of Sleep and Pain Phenotype
- Condition
- Multiple Sclerosis; Sleep; Pain
- Substance studied
- Cannabidiol (CBD); Dronabinol (synthetic THC); THC (tetrahydrocannabinol)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Ann Arbor, United States
- Registry number
- NCT05269628 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effectiveness of Oral Cannabis Extracts for Osteoarthritic Pain: an Internal Pilot, Placebo Controlled, Blinded Randomized Trial
- Condition
- Osteoarthritis of Knee; Osteoarthritis Hip
- Substance studied
- Cannabidiol (CBD); THC (tetrahydrocannabinol)
- Phase
- Not applicable
- Age group
- 40 years to 80 years (adults, older adults)
- Countries
- Canada
- Locations
- Toronto, Canada; Montreal, Canada
- Registry number
- NCT06878417 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Combination of THC and CBD as Novel Treatment for Co-Occurring Opioid Use Disorder and Chronic Pain
- Condition
- Chronic Pain; Opioid Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- New Haven, United States
- Registry number
- NCT06544291 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effects of Dronabinol in Opioid-Related Outcomes
- Condition
- Pain
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Early phase 1
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT04025359 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase I Study of the Effects of Cannabis on Cancer Burden: Placebo-Controlled, Double-Blind, Randomized Trial
- Condition
- Cancer; Cancers, Pain
- Substance studied
- THC (tetrahydrocannabinol); Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT06601218 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Full-Spectrum Cannabidiol Oil on Symptoms of Treatment-Resistant Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
- Condition
- Major Depressive Disorder (MDD); Treatment-resistant Depression (TRD)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 18 years to 69 years (adults, older adults)
- Countries
- Brazil
- Locations
- Tubarão, Brazil
- Registry number
- NCT07696871 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabis and Memory
- Condition
- Cannabis; Memory; Electroencephalography
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Observational study
- Age group
- 21 years to 40 years (adults)
- Countries
- United States
- Locations
- Boulder, United States
- Registry number
- NCT07679581 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
- Condition
- Refractory Epilepsy in Children; Refractory Epilepsy; Epilepsy
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 1 year to 18 years (children, adults)
- Countries
- Netherlands
- Locations
- Utrecht, Netherlands
- Registry number
- NCT07668856 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study
- Condition
- Healthy Volunteer
- Substance studied
- THC (tetrahydrocannabinol); Cannabidiol (CBD)
- Phase
- Not applicable
- Age group
- 18 years to 60 years (adults)
- Countries
- United Kingdom
- Locations
- London, United Kingdom
- Registry number
- NCT07656350 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
- Condition
- Opioid Use Disorder
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT05729932 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Phase 1 Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
- Condition
- Major Depression Disorder; Depression
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT06671977 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies
- Condition
- Alcohol Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2 and 3
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT05613608 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
- Condition
- Mild Cognitive Impairment
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 55 years to 85 years (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT05822362 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effects of THC on Glucose Metabolism and Endothelial Function in Subjects With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- La Jolla, United States
- Registry number
- NCT05322213 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial
- Condition
- Cannabis Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Boulder, United States
- Registry number
- NCT06107062 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
THC Titration of High-Potency Cannabis Concentrates: A Randomized Cross-Over Trial
- Condition
- THC
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Not applicable
- Age group
- 19 years to 55 years (adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT07105449 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Rocky Mountain Cannabis Research Center, Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo-Controlled Study
- Condition
- Sleep; Anxiety; Depression; Pain
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 60 years and older (adults, older adults)
- Countries
- United States
- Locations
- Boulder, United States
- Registry number
- NCT06290063 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Use of Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis. A Double-Blind, Randomized Control Study
- Condition
- Knee Arthritis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2 and 3
- Age group
- 40 years to 75 years (adults, older adults)
- Countries
- United States
- Locations
- New York, United States
- Registry number
- NCT05020028 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
- Condition
- Interaction
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 21 years to 64 years (adults)
- Countries
- United States
- Locations
- Spokane, United States
- Registry number
- NCT06692933 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Brain Mechanisms Supporting Cannabis-induced Pain Relief
- Condition
- Sciatica; Lumbar Radiculopathy; Lower Back Pain; Degenerative Disc Disease; Chronic Low-back Pain (cLBP); Chronic Low Back and Leg Pain; Back Pain
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Early phase 1
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- La Jolla, United States
- Registry number
- NCT04982965 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Pragmatic Trial of Cannabidiol to Improve Chronic Pain Symptoms Among Veterans
- Condition
- Pain, Chronic
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Ann Arbor, United States
- Registry number
- NCT06213233 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Behavioral Pharmacology of Orally Administered THC and D-limonene
- Condition
- Subjective Drug Effects; THC; D-limonene
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06378957 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Potential Effects of Cannabigerol in Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (CAN-ADHD)
- Condition
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Substance studied
- Cannabigerol (CBG)
- Phase
- Phase 1 and 2
- Age group
- 12 years to 17 years (children)
- Countries
- Brazil
- Locations
- Tubarão, Brazil
- Registry number
- NCT07592390 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Explore the Safety and Therapeutic Potential of Dronabinol as an Adjunct for Reducing Pain
- Condition
- Low Back Pain; Chronic Pain; Back Injuries
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 18 years to 64 years (adults)
- Countries
- United States
- Locations
- Houston, United States
- Registry number
- NCT06454669 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Pilot Study to Evaluate the Feasibility, Safety, and Efficacy of Cannabigerol/Cannabidiol Oil for Chemotherapy-Induced Peripheral Neuropathy
- Condition
- Chemotherapy-Induced Peripheral Neuropathy
- Substance studied
- Cannabigerol (CBG)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Hershey, United States
- Registry number
- NCT07016971 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Effect of CBD on Sleep Quality Following Late Evening Exercise
- Condition
- Sleep Quality
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 40 years (adults)
- Countries
- Belgium
- Locations
- Leuven, Belgium
- Registry number
- NCT07570472 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Randomized, Placebo Controlled Study of Cannabidiol in Young Adult Cannabis Users
- Condition
- Cannabis Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 25 years (adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT06569394 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study
- Condition
- Cannabis Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 25 years to 60 years (adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT06575751 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV
- Condition
- HIV; Cannabis; THC; Neuroinflammatory Disease; Neuroinflammatory Response; Microbiome
- Substance studied
- Cannabinol (CBN); Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- San Diego, United States
- Registry number
- NCT05514899 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabis for the Prophylactic Treatment of Migraine: a Randomized Double-Blind Placebo-Controlled Clinical Trial
- Condition
- Chronic Migraine
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 25 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Calgary, Canada
- Registry number
- NCT03972124 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol Effects on Learning and Anxiety
- Condition
- Anxiety and Fear
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years to 50 years (adults)
- Countries
- United States
- Locations
- Storrs, United States
- Registry number
- NCT05283382 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
- Condition
- Diabetic Peripheral Neuropathic Pain (DPN); Diabetic Neuropathies
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 40 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- Tallahassee, United States
- Registry number
- NCT07298408 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
- Condition
- Cannabis
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT04704271 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Using Cannabis to Treat Restless Legs Syndrome: A Randomized Placebo Controlled Pilot Safety and Feasibility Trial
- Condition
- Restless Leg Syndrome (RLS)
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 25 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT06863740 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol (CBD) As A Pain Adjunct in Orthopedic Surgical Patients: A Randomized Control Trial
- Condition
- Shoulder Osteoarthritis; Rotator Cuff Injuries
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Houston, United States
- Registry number
- NCT06381791 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty, a Randomized, Two by Two Factorial, Double-blind, Placebo-controlled Clinical Trial
- Condition
- Knee Replacement Surgery; Osteoarthritis, Knee
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 80 years (adults, older adults)
- Countries
- United States
- Locations
- Ann Arbor, United States; Detroit, United States
- Registry number
- NCT06234631 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Use
- Condition
- Tobacco Use Disorder; Tobacco Smoking; Tobacco Dependence
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- North Hollywood, United States
- Registry number
- NCT06218056 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
- Condition
- Cannabis Use
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT05602649 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics: Electronic Cigarette Use
- Condition
- Cannabis Use; Tobacco Use; Electronic Cigarette Use
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06609109 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
- Condition
- Bipolar Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Belmont, United States
- Registry number
- NCT05457465 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Influence of Age on Driving-related Cannabis Effects: Exploring Cannabis Use Frequency and Related Factors
- Condition
- Cannabis
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 19 years to 45 years (adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT04325958 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes
- Condition
- Driving Under the Influence
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 19 years to 45 years (adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT05526196 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
- Condition
- Menopause; Perimenopause
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 40 years to 60 years (adults)
- Countries
- United States
- Locations
- Pullman, United States
- Registry number
- NCT07393672 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
- Condition
- Neuropathic Pain; Peripheral Neuropathic Pain
- Substance studied
- Dronabinol (synthetic THC); Cannabidiol (CBD); Nabiximols (THC and CBD oromucosal spray)
- Phase
- Phase 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- San Diego, United States; West Los Angeles, United States; West Haven, United States; Providence, United States; San Antonio, United States; Seattle, United States
- Registry number
- NCT05351801 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Investigation of Psychedelic Effects in Psychoactive Substances
- Condition
- Psychedelic Effects in Healthy Volunteers
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 1
- Age group
- 25 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06772753 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
The Influence of Female Sex Hormones on the Subjective and Cognitive Response to Cannabis
- Condition
- Cannabis
- Substance studied
- Cannabinol (CBN); Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 18 years to 40 years (adults)
- Countries
- Netherlands
- Locations
- Maastricht, Netherlands
- Registry number
- NCT07417059 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol for Treating PTSD Symptoms and Neurocognitive Impairment in PTSD and PTSD Comorbid With TBI: A Placebo-controlled RCT With Neural-circuit Centered Precision Medicine Prediction of Response.
- Condition
- Post Traumatic Stress Disorder; Traumatic Brain Injury
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- New York, United States
- Registry number
- NCT04550377 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
ICONICplus, Randomized, Double-blind, Placebo-controlled Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Cue-Induced Alcohol Craving in Alcohol Dependence
- Condition
- Alcohol Addiction; Alcoholism
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- Germany
- Locations
- Wiesloch, Germany; Mannheim, Germany
- Registry number
- NCT06845124 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Study of the Passage of (CBD) Into Breast Milk and Its Biological Impact on Breast-fed Children
- Condition
- Breast Feeding
- Substance studied
- Cannabidiol (CBD)
- Phase
- Not applicable
- Age group
- 18 years and older (adults, older adults)
- Countries
- France
- Locations
- Orléans, France
- Registry number
- NCT06589258 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- Condition
- Back Pain; Neck Pain
- Substance studied
- Cannabidiol (CBD); THC (tetrahydrocannabinol)
- Phase
- Phase 3
- Age group
- 21 years to 84 years (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT05052541 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics: Cigarette Use
- Condition
- Cannabis Use; Tobacco Use; Cigarette Smoking
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06609083 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis: Understanding the Mechanism and Mediators of Action
- Condition
- Early Psychosis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 16 years to 30 years (children, adults)
- Countries
- United States
- Locations
- La Jolla, United States; San Diego, United States
- Registry number
- NCT04411225 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Oral Cannabidiol for Tobacco Cessation
- Condition
- Tobacco Use; Tobacco Smoking; Tobacco Dependence; Tobacco Use Disorder; Tobacco Use Cessation
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT05445804 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Sex- and AGE-dependent Effects of Smoked and Oral Delta-9-THC
- Condition
- Pain; Abuse, Drug; Intoxication; Cannabinoids
- Substance studied
- THC (tetrahydrocannabinol); Dronabinol (synthetic THC)
- Phase
- Phase 1
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- Los Angeles, United States
- Registry number
- NCT05865470 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
- Condition
- THC; Cannabis; Cannabis Use; Cannabis Smoking; Tobacco Use; Vaping
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- San Francisco, United States
- Registry number
- NCT05999383 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
CANBiome: Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
- Condition
- Driving Under the Influence of Cannabis
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- Switzerland
- Locations
- Basel, Switzerland
- Registry number
- NCT06975020 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Modulation of ∆9-tetrahydrocannabinol Acute Psychoactive Effects by Ranging Doses of Cannabidiol in Healthy, Occasional Cannabis Users: a Controlled, Triple Blind, Randomized, Cross-over Study
- Condition
- Cannabis; THC
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 1 and 2
- Age group
- 21 years to 49 years (adults)
- Countries
- Canada
- Locations
- Montreal, Canada
- Registry number
- NCT06099379 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Interactions Between Delta-9-THC and CBD: A Controlled Human Drug-administration Study Probing a Harm Reduction Strategy
- Condition
- Abuse, Drug; Pain
- Substance studied
- THC (tetrahydrocannabinol); Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 21 years to 55 years (adults)
- Countries
- United States
- Locations
- Los Angeles, United States
- Registry number
- NCT06859710 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy
- Condition
- Breast Carcinoma; Chemotherapy-Induced Peripheral Neuropathy; Colon Carcinoma
- Substance studied
- Cannabidiol (CBD); Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Duarte, United States; Irvine, United States
- Registry number
- NCT06731894 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: A Phase II Trial
- Condition
- Severe Alcohol Use Disorder (DSM 5)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 75 years (adults, older adults)
- Countries
- France
- Locations
- Créteil, France; Clamart, France; Clermont-Ferrand, France; Colombes, France; Bobigny, France; Paris, France
Show all 8 locations
Créteil, France; Clamart, France; Clermont-Ferrand, France; Colombes, France; Bobigny, France; Paris, France; Sevran, France; Montpellier, France - Registry number
- NCT05860699 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Efficacy of Topical Cannabidiol Lotion for Pruritus Relief, Hydrating, Sleep Quality, Quality of Life Improvement in Systemic Sclerosis: a Randomized Double Blinded Controlled Crossover Trial
- Condition
- Mediciine; Systemic Sclerosis (SSc); Intervention Study
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- Thailand
- Locations
- Khon Kaen, Thailand
- Registry number
- NCT07245238 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study to Assess the Safety, Tolerability and Efficacy of Terpenes-enriched Cannabis Oil T1/C28, Administered to Pediatric Subjects With Autism Spectrum Disorder (ASD)
- Condition
- Autism; Autism Spectrum Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 4 years to 13 years (children)
- Countries
- Israel
- Locations
- Jerusalem, Israel
- Registry number
- NCT07199218 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Sex Differences in the Interface Between Cannabis Use and Stress Among Emerging Adults
- Condition
- Cannabis Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 18 years to 25 years (adults)
- Countries
- United States
- Locations
- Charleston, United States
- Registry number
- NCT05885542 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Pilot fMRI Studies of Aging-Related Effects of THC
- Condition
- THC
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 2
- Age group
- 18 years to 75 years (adults, older adults)
- Countries
- United States
- Locations
- Hartford, United States
- Registry number
- NCT06647524 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement: A Double Blinded, Randomized, 24 Hours Follow-up Study
- Condition
- Acute Radicular Back Pain; Cannabis
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 3
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- Israel
- Locations
- Jerusalem, Israel
- Registry number
- NCT04816994 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Dronabinol for the Reduction of Chronic Pain and Inflammation in People With Sickle Cell Disease
- Condition
- Sickle Cell Disease
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- New York, United States
- Registry number
- NCT05519111 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Sub-Lingual Administration of Cannabidiol for Knee Osteoarthritis
- Condition
- Osteoarthritis, Knee
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 40 years to 75 years (adults, older adults)
- Countries
- United States
- Locations
- Gainesville, United States
- Registry number
- NCT06414473 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC
- Condition
- Sleep; Anxiety; Depression; Pain
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 25 years and older (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT06266611 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of an Acute 1-month Cannabidiol Treatment on Pain and Inflammation After a Long Bone Fracture: a Triple-blind Randomized, Placebo Controlled Clinical Trial
- Condition
- Fracture
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 70 years (adults, older adults)
- Countries
- Canada
- Locations
- Montreal, Canada
- Registry number
- NCT06448923 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Treatment of Sickle Cell Pain and Inflammation With Cannabidiol (SPICe)
- Condition
- Sickle Cell Disease
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Manhattan, United States
- Registry number
- NCT06930703 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
- Condition
- Cannabis
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT02811510 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
- Condition
- Cannabis
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT02781519 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Trial
- Condition
- Chronic Migraine
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 14 years to 17 years (children)
- Countries
- Canada
- Locations
- Vancouver, Canada; Halifax, Canada; Toronto, Canada
- Registry number
- NCT05337033 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
- Condition
- Fibromyalgia
- Substance studied
- Cannabidiol (CBD); Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 30 years and older (adults, older adults)
- Countries
- Israel
- Locations
- Haifa, Israel
- Registry number
- NCT06946940 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind, Placebo Controlled Trial
- Condition
- Bipolar Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 19 years to 70 years (adults, older adults)
- Countries
- Canada
- Locations
- Vancouver, Canada; Hamilton, Canada; Kingston, Canada; Toronto, Canada; Montreal, Canada
- Registry number
- NCT05867849 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults
- Condition
- Pharmacokinetics
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 35 years (adults)
- Countries
- Canada
- Locations
- Saskatoon, Canada
- Registry number
- NCT06574100 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Phase I Clinical Trial to Assess Tolerability, Safety, and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare 79.14 mg/mL, Drops Solution, in Healthy Research Participants of Both Sexes in a Fed State
- Condition
- Healthy
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- Brazil
- Locations
- Vinhedo, Brazil
- Registry number
- NCT06807762 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Efficacy of Cannabinoids to the Current Standard Treatments on Symptom Relief in Persons With Multiple Sclerosis: Randomized Controlled Trial
- Condition
- Multiple Sclerosis
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- Canada
- Locations
- Montreal, Canada
- Registry number
- NCT05092191 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Evaluate Safety and Tolerability of Cannabidiol (Kanbis®) for the Treatment of Parkinson's Disease Symptoms
- Condition
- Parkinson Disease
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 40 years to 80 years (adults, older adults)
- Countries
- Argentina
- Locations
- Mendoza, Argentina
- Registry number
- NCT06629389 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
- Condition
- Cannabis Use Disorder
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2
- Age group
- 21 years to 40 years (adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT06446479 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
A Phase 2a Study on the Anti-tumoral Effect of Cannabis Oil (THC 10% / CBD 5%) in Patients With Advanced Untreatable Hepatocellular Carcinoma
- Condition
- Hepatocellular Carcinoma; Cannabis
- Substance studied
- Cannabinol (CBN)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- Netherlands
- Locations
- Groningen, Netherlands
- Registry number
- NCT06518434 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study
- Condition
- Cancer; Epilepsy; Neurodevelopmental Disorders
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Observational study
- Age group
- 3 years to 17 years (children)
- Countries
- Canada
- Locations
- Winnipeg, Canada
- Registry number
- NCT05863910 (ClinicalTrials.gov)
- Registry last updated
-
Recruiting
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
- Condition
- Alzheimer Disease; Dementia; Major Neurocognitive Disorder With Aggressive Behavior
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 50 years to 90 years (adults, older adults)
- Countries
- United States
- Locations
- Norfolk, United States
- Registry number
- NCT04436081 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Acute Effects of Sequential Nicotine Vaping on the Pharmacokinetic and Pharmacodynamic Properties of Vaped THC: A Randomized Within-Subject Crossover Study
- Condition
- Cannabis Dependence
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Early phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Buffalo, United States
- Registry number
- NCT06334016 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Efficacy of Vaped Cannabidiol in Cannabis Use Disorder
- Condition
- Cannabis Use Disorder
- Substance studied
- Cannabidiol (CBD)
- Phase
- Not applicable
- Age group
- 18 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07933081 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Substance Use and Media Preferences
- Condition
- Substance Use Behavior; Cannabis Intoxication; Alcohol Intoxication
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- 21 years to 30 years (adults)
- Countries
- United States
- Locations
- Denver, United States
- Registry number
- NCT07922239 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Phase 1, Single Center, Open-Label, Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Cannabidiol Capsules (AVAT-121) and Epidyolex® in Healthy Male and Female Adult Participants, Including Japanese Adults
- Condition
- Focal Onset Seizure
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07918469 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Randomized Within-Subject Cross-Over Study to Compare Short-Term PK/PD Effects of Vaping THC-containing Liquids vs. Smoked Cannabis
- Condition
- Cigarette Smoking-Related Carcinoma
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT06055231 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Lung Health and Breath Biomarkers: Acute Effects of Combusted and Vaporized Cannabis Inhalation Compared to Tobacco Cigarette Combustion in the Human Laboratory
- Condition
- Cannabis Use; Tobacco; Biomarkers
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Early phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT07694466 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects of Cannabidiol on Memory and Attention in Adults Aged 60-70 Years: A Pilot Study
- Condition
- Healthy Aging; Cognition
- Substance studied
- Cannabidiol (CBD)
- Phase
- Not applicable
- Age group
- 60 years to 70 years (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07910292 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Novel endOvascular Therapy With beVAcizumab and Cannabinoids for Glioblastoma
- Condition
- GBM
- Substance studied
- Nabiximols (THC and CBD oromucosal spray)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07909811 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Prospective Evaluation of Cannariver CBD Calm in Adults With Generalized Anxiety Disorder: An Open-Label, Single-Group, Non-Randomized Interventional Study
- Condition
- Generalized Anxiety Disorder
- Substance studied
- Cannabigerol (CBG)
- Phase
- Not applicable
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07821840 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Phase 3b/4, Interventional, Prospective, Multicenter, Open-Label Study Evaluating the Effectiveness of a Gradual Titration Regimen to Optimize CBD-OS as Add-On Therapy in Adults With Lennox-Gastaut Syndrome
- Condition
- Lennox-Gastaut Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 4
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Fresno, United States; New Orleans, United States; Raleigh, United States
- Registry number
- NCT07728097 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Research Investigating Drug Effects-2 (RiDE-2)
- Condition
- Cannabis Use; Substance Use Disorder (SUD); Healthy
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Early phase 1
- Age group
- 18 years to 21 years (adults)
- Countries
- United States
- Locations
- Chicago, United States
- Registry number
- NCT06758596 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
- Condition
- Cannabis Use; Impaired Driving; Cognitive Impairment
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 18 years to 60 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT06351540 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Bridging the Neurocomputational Explanations of Paranoia: From Cognition to Clinic
- Condition
- None Volunteer
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 2
- Age group
- 18 years to 65 years (adults, older adults)
- Countries
- United Kingdom
- Locations
- London, United Kingdom
- Registry number
- NCT07878130 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)
- Condition
- Cannabis Intoxication
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT07870187 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Impact of Cannabis on Opioid Self-Administration
- Condition
- Opioid Use Disorder; Cannabis Use
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT07668635 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Cannabis and Opioid Use Disorder, Study 2
- Condition
- Opioid Use Disorders; Cannabis Use
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Lexington, United States
- Registry number
- NCT07661446 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
ImPRoving OutcoMes in Individuals at Clinical High Risk fOr Psychosis Using Cannabidiol: a Double-blind, Randomised conTrollEd Trial
- Condition
- Clinical High Risk for Psychosis (CHR); Clinical High Risk for Psychosis; Clinical High Risk for Developing Psychosis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 12 years to 35 years (children, adults)
- Countries
- Austria, Canada, Finland, Germany, Greece, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Locations
- Vienna, Austria; Montreal, Canada; Turku, Finland; Berlin, Germany; Cologne, Germany; Lübeck, Germany
Show all 19 locations
Vienna, Austria; Montreal, Canada; Turku, Finland; Berlin, Germany; Cologne, Germany; Lübeck, Germany; München, Germany; Athens, Greece; Bari, Italy; Naples, Italy; Pavia, Italy; Roma, Italy; Amsterdam, Netherlands; Bilbao, Spain; Madrid, Spain; Zurich, Switzerland; Cambridge, United Kingdom; London, United Kingdom; Oxford, United Kingdom - Registry number
- NCT07434973 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Full Title: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis: a Double-blind, Randomised Controlled Trial
- Condition
- Treatment Resistant Psychosis; Psychosis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 16 years to 50 years (children, adults)
- Countries
- Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Locations
- Berlin, Germany; Cologne, Germany; Munich, Germany; Athens, Greece; Hod HaSharon, Israel; Petah Tikva, Israel
Show all 15 locations
Berlin, Germany; Cologne, Germany; Munich, Germany; Athens, Greece; Hod HaSharon, Israel; Petah Tikva, Israel; Ramat Gan, Israel; Naples, Italy; Amsterdam, Netherlands; Madrid, Spain; Seville, Spain; Zurich, Switzerland; Cambridge, United Kingdom; London, United Kingdom; Oxford, United Kingdom - Registry number
- NCT07326124 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Randomized, Double-blind, Placebo-controlled Parallel Study of the Tolerability and Efficacy of High Cannabidiol (CBD) Cannabis Extract for the Treatment of Patients With Idiopathic Restless Legs Syndrome (RLS)
- Condition
- Restless Leg Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 79 years (adults, older adults)
- Countries
- United States
- Locations
- Aurora, United States
- Registry number
- NCT07224932 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects Of Nocturnal Dronabinol Use On Obstructive Sleep Apnea Treatment And Physiological Outcomes
- Condition
- Obstructive Sleep Apnea
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2 and 3
- Age group
- 21 years to 70 years (adults, older adults)
- Countries
- United States
- Locations
- Rochester, United States
- Registry number
- NCT07570953 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Clinical Study of the Transition of Children From 'Artisanal' Cannabidiol to Epidiolex
- Condition
- Dravet Syndrome (DS); Lennox-Gastaut Syndrome (LGS)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 4
- Age group
- 2 years to 18 years (children, adults)
- Countries
- Canada
- Locations
- Toronto, Canada
- Registry number
- NCT06924827 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects Of Cannabis Products On Blood Pressure Control
- Condition
- Blood Pressure
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2 and 3
- Age group
- 21 years to 40 years (adults)
- Countries
- United States
- Locations
- Rochester, United States
- Registry number
- NCT07231965 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Topical Cannabidiol for Plantar Fasciitis: A Double-Blinded Study on Rapid and Sustained Pain Relief
- Condition
- Plantar Fasciitis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 85 years (adults, older adults)
- Countries
- United States
- Locations
- Gainesville, United States
- Registry number
- NCT07776405 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
- Condition
- PTSD; Post Traumatic Stress Disorder; Suicide; Cannabis Use
- Substance studied
- Cannabidiol (CBD); Cannabinol (CBN)
- Phase
- Phase 1 and 2
- Age group
- 18 years to 60 years (adults)
- Countries
- United States
- Locations
- Detroit, United States
- Registry number
- NCT06222268 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Evaluation of Bone Turnover Biomarkers, CB2 and TRPV1 Polymorphisms as Potential Preventive Data in Osteoporosis and Perception of Improvement in Quality of Life in Women With Chronic Pain Treated With Medicinal Cannabis
- Condition
- Chronic Pain; Fibromyalgia; Osteoporosis; Orofacial Pain
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 45 years to 80 years (adults, older adults)
- Countries
- Brazil
- Locations
- São Paulo, Brazil
- Registry number
- NCT07783295 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)
- Condition
- Post Traumatic Stress Disorder PTSD
- Substance studied
- THC (tetrahydrocannabinol); Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07224698 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Development of Tetrahydrocannabivarin as a Treatment for Smokers
- Condition
- Tobacco Use Disorder; Smoking Cessation
- Substance studied
- Tetrahydrocannabivarin (THCV)
- Phase
- Phase 2
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07636356 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Behavioral Pharmacology of THC and Beta-Myrcene
- Condition
- Cannabis Use
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 1
- Age group
- 18 years to 55 years (adults)
- Countries
- United States
- Locations
- Baltimore, United States
- Registry number
- NCT05432284 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Evaluation of the Effects of Isolated Cannabidiol (CBD) on Inflammation, Pain, Sleep and Quality of Life in Brazilian Jiu-Jitsu Athletes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Condition
- Pro and Anti Inflamatory Cytokines; Pain; Sleep; Quality of Life
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2 and 3
- Age group
- 18 years to 40 years (adults)
- Countries
- Brazil
- Locations
- São Paulo, Brazil
- Registry number
- NCT07552974 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Cannabidiol Oral Solution (CBD-OS, JZP926-OS) in Participants Aged 1 Year and Older With Developmental and Epileptic Encephalopathy (DEE)
- Condition
- Developmental and Epileptic Encephalopathy (DEE)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 1 year and older (children, adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07723976 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
- Condition
- Non-metastatic Bladder Cancer
- Substance studied
- Cannabigerol (CBG)
- Phase
- Early phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Palo Alto, United States
- Registry number
- NCT07577999 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study
- Condition
- Pruritus
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- France
- Locations
- Angers, France; La Roche-sur-Yon, France; La Rochelle, France; Nantes, France; Poitiers, France; Tours, France
- Registry number
- NCT06435299 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use
- Condition
- Sleep; Alcohol Misuse
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07527338 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Triple-Blind, Placebo-Controlled, Randomized Clinical Trial of CANnabinoids for Drug Resistant Epilepsy in Adults and Children
- Condition
- Drug Resistant Epilepsy
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 24 months to 55 years (children, adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT07023744 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Pilot Study Using Topical Cannabidiol (CBD) to Manage Osteoarthritic Knee Pain
- Condition
- Osteoarthitis
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Memphis, United States
- Registry number
- NCT07638189 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
- Condition
- Opioid Use Disorder
- Substance studied
- Dronabinol (synthetic THC); Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- The Bronx, United States
- Registry number
- NCT07148206 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Medical Cannabis Observational Study for Antiemetic Intervention in Chemotherapy
- Condition
- Nausea and Vomiting Chemotherapy-Induced
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Observational study
- Age group
- 21 years and older (adults, older adults)
- Countries
- United States
- Locations
- Rochester, United States
- Registry number
- NCT07374939 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes
- Condition
- Persistent Post Traumatic Headache
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years to 75 years (adults, older adults)
- Countries
- United States
- Locations
- Scottsdale, United States; Los Angeles, United States; Washington D.C., United States; Tampa, United States; Kansas City, United States; Shrewsbury, United States
Show all 8 locations
Scottsdale, United States; Los Angeles, United States; Washington D.C., United States; Tampa, United States; Kansas City, United States; Shrewsbury, United States; Cleveland, United States; Pittsburgh, United States - Registry number
- NCT07624279 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.
- Condition
- Neurodevelopmental Disorders With Severe Self-injuries
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 5 years to 17 years (children)
- Countries
- France
- Locations
- Paris, France
- Registry number
- NCT07564245 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
The Effects of Topical Cannabidiol on Paramedian Forehead Flap Scar Healing: A Split Scar Study
- Condition
- Forehead; Wound
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years to 99 years (adults, older adults)
- Countries
- United States
- Locations
- Oklahoma City, United States
- Registry number
- NCT05650697 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users: A Randomised Placebo-Controlled Experimental Study (Stage 1)
- Condition
- Cannabis Intoxication
- Substance studied
- Cannabinol (CBN)
- Phase
- Not applicable
- Age group
- 18 years to 45 years (adults)
- Countries
- United Kingdom
- Locations
- London, United Kingdom
- Registry number
- NCT07471347 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study
- Condition
- Drug Drug Interaction
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 45 years (adults)
- Countries
- Finland
- Locations
- Helsinki, Finland
- Registry number
- NCT07462559 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden (CAPTURE)
- Condition
- Advanced Malignant Solid Tumor
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- Italy
- Locations
- Naples, Italy
- Registry number
- NCT07459920 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Phase 2/3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease
- Condition
- Agitation in Dementia
- Substance studied
- Dronabinol (synthetic THC)
- Phase
- Phase 2 and 3
- Age group
- 50 years to 90 years (adults, older adults)
- Countries
- Australia
- Locations
- Bedford Park, Australia
- Registry number
- NCT07422311 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Clinical Trial Policy Study for the Objective Comparison of Cannabis Vs Opioids (CVO) Pain Management and Therapy Types for Circulatory and Chronic Pain Issues
- Condition
- Chronic Pain; Circulatory Disorders
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Not applicable
- Age group
- up to 90 years (children, adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT03734731 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Randomized, Triple Blinded Cross-over Placebo Controlled Study of Effects of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
- Condition
- Cannabis
- Substance studied
- Cannabis (plant material or extract)
- Phase
- Phase 1 and 2
- Age group
- 21 years to 49 years (adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT05320367 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Randomized, Double-blind, Placebo-controlled, 2x2 Cross Over Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer
- Condition
- Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage III; HR+ Breast Cancer; AI-related Musculoskeletal Pain
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 3
- Age group
- 18 years and older (adults, older adults)
- Countries
- France
- Locations
- Villejuif, France
- Registry number
- NCT06787118 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity Induced by Tooth Bleaching
- Condition
- Dentin Sensitivity
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years to 40 years (adults)
- Countries
- Brazil
- Locations
- Belém, Brazil
- Registry number
- NCT07027566 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks
- Condition
- THC
- Substance studied
- THC (tetrahydrocannabinol)
- Phase
- Phase 2
- Age group
- 21 years to 65 years (adults, older adults)
- Countries
- United States
- Locations
- West Haven, United States
- Registry number
- NCT05641766 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Carpal Tunnel Syndrome
- Condition
- Carpal Tunnel Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 18 years and older (adults, older adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT06108349 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain
- Condition
- Upper Extremity Muscle Pain; Upper Extremity Bone Pain; Upper Extremity Pain
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1
- Age group
- 18 years and older (adults, older adults)
- Countries
- United States
- Locations
- Charlottesville, United States
- Registry number
- NCT06695195 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects of Marijuana on Memory-Related Neurochemistry and Neural Response
- Condition
- Marijuana Use; Cannabis Use; Cannabis Intoxication
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years to 40 years (adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT04855526 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effect of CBD on the GABAergic System in Patients with Fragile X Syndrome.
- Condition
- Fragile X Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 2
- Age group
- 7 years to 55 years (children, adults)
- Countries
- Not listed
- Locations
- Not listed in the registry
- Registry number
- NCT06261450 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome
- Condition
- Lennox-Gastaut Syndrome (LGS); Dravet Syndrome (DS)
- Substance studied
- Cannabidiol (CBD)
- Phase
- Phase 1 and 2
- Age group
- 2 years to 55 years (children, adults)
- Countries
- United States
- Locations
- Boston, United States
- Registry number
- NCT06738732 (ClinicalTrials.gov)
- Registry last updated
-
Not yet recruiting
Effects of Cannabidiol on Burnout Syndrome and Empathy of Paid and Unpaid Caregivers of Older Adults
- Condition
- Burnout Syndrome
- Substance studied
- Cannabidiol (CBD)
- Phase
- Early phase 1
- Age group
- 18 years to 50 years (adults)
- Countries
- Brazil
- Locations
- Ribeirão Preto, Brazil
- Registry number
- NCT06617247 (ClinicalTrials.gov)
- Registry last updated
How this list is made
We search the ClinicalTrials.gov API for studies with the status recruiting or not yet recruiting, using the search words cannabidiol, cannabis, THC, tetrahydrocannabinol, cannabinoid, nabiximols, dronabinol, nabilone, cannabigerol, endocannabinoid, cannabinol, cannabidivarin, tetrahydrocannabivarin and marijuana. A study is listed only if a cannabinoid appears in its list of interventions. Studies that mention cannabis only in their eligibility criteria, or that study other treatments for cannabis use, are left out. Substance names are shown as generic names. Condition groups in the filter are assigned automatically from the registry condition terms and may not be perfect. The group Effects of cannabis (healthy volunteer studies) contains only studies that accept healthy volunteers or are human laboratory studies of how cannabinoids act in the body; studies in patients are listed under their condition instead. These studies measure effects and risks and are not an invitation to use cannabis. Study sponsors are not shown; they are on the registry page.
Registry data can be incomplete or out of date. CannaQ does not check eligibility, does not contact study teams and does not receive anything from any trial.